Orange Book product · Generic (ANDA)
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
MAGNESIUM SULFATE
At a glance
Sep 10, 2018
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 10, 2018
7 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
MAGNESIUM SULFATE
Strength
1GM/100ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 209932
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MAGNESIUM SULFATE
- 2007MAGNESIUM SULFATE IN PLASTIC CONTAINERBrand (NDA)
NDA 020309 · HOSPIRA
- 1995MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINERBrand (NDA)
NDA 020488 · HOSPIRA
- 1986MAGNESIUM SULFATEBrand (NDA)
NDA 019316 · FRESENIUS KABI USA
- 2026MAGNESIUM SULFATEGeneric (ANDA)
ANDA 211966 · BAXTER HLTHCARE CORP
- 2025MAGNESIUM SULFATEGeneric (ANDA)
ANDA 219777 · ASPIRO
- 2023MAGNESIUM SULFATE IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 216597 · AMNEAL
- 2021MAGNESIUM SULFATE IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 209642 · MILLA PHARMS
- 2021MAGNESIUM SULFATEGeneric (ANDA)
ANDA 207967 · B BRAUN MEDICAL
- 2020MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 207966 · B BRAUN MEDICAL
- 2020MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 211965 · BAXTER HLTHCARE CORP
- 2020MAGNESIUM SULFATE IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 213917 · GLAND
- 2018MAGNESIUM SULFATE IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 209911 · MYLAN LABS LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
